Related Experiment Video

Updated: Jun 14, 2026

Murine Aortic Crush Injury: An Efficient In Vivo Model of Smooth Muscle Cell Proliferation and Endothelial Function
06:14

Murine Aortic Crush Injury: An Efficient In Vivo Model of Smooth Muscle Cell Proliferation and Endothelial Function

Published on: June 11, 2017

An essential role of PDCD4 in vascular smooth muscle cell apoptosis and proliferation: implications for vascular

Xiaojun Liu1, Yunhui Cheng, Jian Yang

  • 1Department of Anesthesiology, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, NJ, USA.

American Journal of Physiology. Cell Physiology
|April 2, 2010
PubMed

Insights

Programmed cell death 4 (PDCD4) regulates vascular smooth muscle cell (VSMC) apoptosis and proliferation. Downregulation of PDCD4 contributes to vascular disease, suggesting PDCD4 as a therapeutic target.

Area of Science:

  • Vascular Biology
  • Cellular Mechanisms
  • Molecular Medicine

Background:

  • Vascular smooth muscle cell (VSMC) apoptosis and proliferation are key in vascular diseases.
  • Molecular regulators of VSMC apoptosis and proliferation remain incompletely understood.

Purpose of the Study:

  • To investigate the role of programmed cell death 4 (PDCD4) in regulating VSMC apoptosis and proliferation.
  • To elucidate the molecular mechanisms underlying PDCD4's function in VSMCs.

Main Methods:

  • Utilized in vivo (rat carotid artery injury) and in vitro (VSMC culture) models.
  • Employed adenovirus-mediated overexpression (Ad-PDCD4) and small interfering RNA (siRNA) for PDCD4 manipulation.
  • Assessed VSMC apoptosis and proliferation rates.
  • Identified downstream signaling molecules, including activator protein 1.

Main Results:

  • PDCD4 expression was significantly downregulated in injured arteries and stimulated VSMCs.
  • PDCD4 overexpression increased VSMC apoptosis, while PDCD4 knockdown decreased it.
  • PDCD4 modulated VSMC apoptosis in vivo.
  • PDCD4 inhibited VSMC proliferation.
  • Activator protein 1 was identified as a downstream mediator of PDCD4's effects.

Conclusions:

  • PDCD4 is a critical regulator of VSMC apoptosis and proliferation.
  • Reduced PDCD4 expression in vascular disease may lead to VSMC imbalance.
  • PDCD4 represents a potential therapeutic target for proliferative vascular diseases.

More Related Videos

Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro08:28

Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro

Published on: February 15, 2022

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...